Clinical Trial Update: Newcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional Anti-cancer Modalities [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Newcastle Disease Virus for metastatic cancer patients resistant to conventional therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Newcastle Disease Virus (NDV) (Newcastle disease virus)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Metastatic Cancer, Newcastle Disease Virus (NDV) | Phase 2 | Status: WITHDRAWN